Belotecan HCl salt CAS:213819-48-8 is an innovative derivative of camptothecin, a potent DNA topoisomerase I inhibitor renowned for its antitumor properties. This novel compound features a unique functional group that enhances its therapeutic potential and enables its use in various research applications. As a powerful antineoplastic agent, Belotecan HCl salt holds promise in the development of targeted cancer therapies, contributing to more effective and safer treatment options. Available as a reagent-grade compound, it is specifically designed for research purposes, with GMP-grade availability upon request.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.